Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T12:12:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    0.8%
    Check dated 2026-10-25T12:28:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T11:59:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The website’s displayed software revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T13:32:56.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the record history, replacing the previous v3.6.6. This reflects an update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-09-20T08:52:10.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The record history adds a new revision entry (v3.6.6) and removes the previous revision (v3.6.5) from the visible history, updating the page's version trail.
    Difference
    0.1%
    Check dated 2026-08-29T23:38:50.000Z thumbnail image

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.